Top stories last 24h
- π Unmatched 28-quarter streak of over 30% year-over-year revenue growth.
- π° Q4 2025 revenue hit $8.76 billion, beating estimates by 44.6%.
- π Stock fell 19% due to margin compression and lower net income.
- π BLDR joins S&P 500 after 1,100% five-year stock return.
- ποΈ Supplies materials from 570 locations across 43 states.
- π° Revenue grew over 26% annually since 2017 via M&A.
- π Nine analysts rate CBRE 'Moderate Buy' with $180.29 price target.
- π Q1 EPS beat estimates at $1.61 versus expected $1.13.
- π° Revenue surged 18.1% year-over-year to reach $10.53 billion.
- π Folger Nolan Fleming Douglas Capital acquired 3,521 shares worth $939,000 in Q1.
- π° Cigna reported quarterly EPS of $7.79 and revenue of $68.52 billion, beating estimates.
- π― Full-year 2026 EPS guidance set between $30.35 and $30.39 aligns with forecasts.
- π UBS raised Marvell target to $340 citing CXL demand.
- π° Analysts project Marvell CXL revenue hits $1B in 2027.
- π Overall revenue estimates lift Marvell to $23.9B by 2028.